Puma Biotechnology, Inc.PBYINASDAQ
Loading
R&D Expenses Over TimeContracting
Percentile Rank43
3Y CAGR+5.9%
5Y CAGR-8.7%
Year-over-Year Change
Research and development spending
3Y CAGR
+5.9%/yr
vs -25.0%/yr prior
5Y CAGR
-8.7%/yr
Recent acceleration
Acceleration
+30.9pp
Accelerating
Percentile
P43
Within normal range
vs 5Y Ago
0.6x
Contraction
Streak
2 yr
Consecutive growthContracting
| Period | Value | YoY Change |
|---|---|---|
| TTM | $62.03M | +12.9% |
| 2024 | $54.94M | +9.0% |
| 2023 | $50.38M | -3.6% |
| 2022 | $52.24M | -27.3% |
| 2021 | $71.87M | -26.4% |
| 2020 | $97.65M | -26.5% |
| 2019 | $132.85M | -19.4% |
| 2018 | $164.90M | -20.6% |
| 2017 | $207.80M | -6.7% |
| 2016 | $222.80M | - |